We were excited to have Doug Monroe, Project Manager of Biotechnology, Emerging Technology, and Specialty Pharmacy at Kaiser Permanente, share his expertise on the impact of biosimilars on private reimbursement strategies at the World Biosimilar Congress USA.
You can now download Doug’s presentation to find out more about:
- The Kaiser Permanente integrated health care delivery system
- Biosimilar: planning in managed care
- The FDA’s Purple Book
- P&T issues
The World Biosimilar Congress USA is where biopharma developing biosimilars gather to discuss how to access the US market. This year’s event will take place May 19-20 at the Hilton San Diego Resort and Spa.